Suppr超能文献

扩张型心肌病患者肿瘤坏死因子受体超家族 1A 基因突变谱。

Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis.

机构信息

Interdepartmental Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Unit of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.

出版信息

Intern Med J. 2013 Jun;43(6):725-7. doi: 10.1111/imj.12163.

Abstract

Although idiopathic recurrent acute pericarditis (IRAP) is generally presumed to derive from an autoimmune process, increasing interest is currently being devoted to autoinflammatory diseases, a group of disorders of the innate immune system caused by mutations of genes involved in the regulation or activation of the inflammatory response, without any apparent involvement of autoimmunity. The tumour necrosis factor receptor-1-associated periodic syndrome is the most common autosomal dominant autoinflammatory disorder and is caused by mutations in the TNFRSF1A gene encoding the 55-kD receptor for tumour necrosis factor-α. IRAP patients carrying TNFRSF1A gene mutations have been recently described. We report herein the first IRAP patients carrying the rare R104Q and D12E TNFRSF1A gene mutations, thus expanding the spectrum of tumour necrosis factor receptor-1-associated periodic syndrome mutations in IRAP patients.

摘要

虽然特发性复发性急性心包炎(IRAP)通常被认为源自自身免疫过程,但目前人们越来越关注自身炎症性疾病,这是一组由参与炎症反应调节或激活的基因的突变引起的先天免疫系统紊乱,而没有任何明显的自身免疫参与。肿瘤坏死因子受体 1 相关周期性综合征是最常见的常染色体显性自身炎症性疾病,由编码肿瘤坏死因子-α 的 55kDa 受体的 TNFRSF1A 基因突变引起。最近已经描述了携带 TNFRSF1A 基因突变的 IRAP 患者。我们在此报告了首例携带罕见的 R104Q 和 D12E TNFRSF1A 基因突变的 IRAP 患者,从而扩大了 IRAP 患者中肿瘤坏死因子受体 1 相关周期性综合征突变的范围。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验